Company Profiles

driven by the PitchBook Platform

Armetheon

Description

Developer of novel anticoagulants and antibiotics. The company is focused on the development of novel drug candidates for unmet needs in cardiovascular diseases.

2011

Founded

PRIVATE

Status

11-50

Employees

Series B

Latest Deal Type

$24.3M

Latest Deal Amount

$31.6M

Total Amount Raised

Description

Developer of novel anticoagulants and antibiotics. The company is focused on the development of novel drug candidates for unmet needs in cardiovascular diseases.

Website:

www.armetheon.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Other Pharmaceuticals and Biotechnology
Discovery Tools (Healthcare)

Primary Office

325 Sharon Park Drive Suite 303 Menlo Park, CA 94025United States
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Armetheon's full profile, request a free trial.

Armetheon Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Armetheon Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Armetheon Investors (11)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Amkey VenturesVenture CapitalMinority000 0000000 0000
AshHill BiomedicalVenture CapitalMinority000 0000000 0000
Atheneos Capital ManagementAccelerator/IncubatorMinority000 0000000 0000
Capital TEN IIVenture CapitalMinority000 0000000 0000
CDIB & Partners Investment HoldingPE/BuyoutMinority000 0000000 0000
Amkey Ventures Venture Capital
AshHill Biomedical Venture Capital
Atheneos Capital Management Accelerator/Incubator
Capital TEN II Venture Capital
CDIB & Partners Investment Holding PE/Buyout

Armetheon Executive Team (9)

NameTitleBoard
Seat
Contact
Info
Sanjay Kakkar MDChief Executive Officer & Board Member
Muralitharan Kengatharan Ph.DBoard Member, Co-Founder & President
Pascal Druzgala Ph.DCo-Founder, Board Member, Senior Vice President, Research & Chief Scientific Officer
Elizabeth Ahrens JDGeneral Counsel & Vice President, Legal
Detlef Albrecht MDChief Medical Officer & Head of Drug Development
Sanjay Kakkar MD Chief Executive Officer & Board Member
Muralitharan Kengatharan Ph.D Board Member, Co-Founder & President
Pascal Druzgala Ph.D Co-Founder, Board Member, Senior Vice President, Research & Chief Scientific Officer
Elizabeth Ahrens JD General Counsel & Vice President, Legal
Detlef Albrecht MD Chief Medical Officer & Head of Drug Development

Armetheon Board Members (5)

NameRepresentingRoleSinceContact
Info
John Saxe JDSelfDirector000 0000
Larry HsuHercules BioventuresGeneral Partner000 0000
Peter Milner MDSelfCo-Founder & Executive Chairman000 0000
Sanjay Kakkar MDArmetheonChief Executive Officer & Board Member000 0000
Steven JamesSelfDirector000 0000
John Saxe JD Director Self
Larry Hsu General Partner Hercules Bioventures
Peter Milner MD Co-Founder & Executive Chairman Self
Sanjay Kakkar MD Chief Executive Officer & Board Member Armetheon
Steven James Director Self
Request full access to PitchBook